Adavosertib with chemotherapy (CT) in patients (pts) with platinum-resistant ovarian cancer (PPROC): An open label, four-arm, phase II study Meeting Abstract


Authors: Moore, K. N.; Chambers, S. K.; Hamilton, E. P.; Chen, L. M.; Oza, A. M.; Ghamande, S. A.; Konecny, G. E.; Plaxe, S. C.; Spitz, D. L.; Geenen, J. J. J.; Troso-Sandoval, T. A.; Cragun, J. M.; Imedio, E. R.; Kumar, S.; Mugundu, G. M.; Lai, Z.; Chmielecki, J.; Jones, S. F.; Spigel, D. R.; Cadoo, K. A.
Abstract Title: Adavosertib with chemotherapy (CT) in patients (pts) with platinum-resistant ovarian cancer (PPROC): An open label, four-arm, phase II study
Meeting Title: 55th Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 37
Issue: 15 Suppl.
Meeting Dates: 2019 May 31-Jun 4
Meeting Location: Chicago, IL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2019-05-20
Start Page: 317s
Language: English
ACCESSION: WOS:000487345805506
DOI: 10.1200/JCO.2019.37.15_suppl.5513
PROVIDER: wos
Notes: Meeting Abstract: 5513 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Karen Anne Cadoo
    113 Cadoo